| 000 | 01276 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515034426.0 | ||
| 264 | 0 | _c20061207 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a0114-5916 | ||
| 024 | 7 |
_a10.2165/00002018-200629080-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSánchez Carazo, Jose L | |
| 245 | 0 | 0 |
_aSafety of etanercept in psoriasis: a critical review. _h[electronic resource] |
| 260 |
_bDrug safety _c2006 |
||
| 300 |
_a675-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadverse effects |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aMahiques Santos, Laura | |
| 700 | 1 | _aOliver Martinez, Vicente | |
| 773 | 0 |
_tDrug safety _gvol. 29 _gno. 8 _gp. 675-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00002018-200629080-00004 _zAvailable from publisher's website |
| 999 |
_c16461392 _d16461392 |
||